Japan Infectious Diagnostics Market Outlook to 2024

Published : Nov-2017

No. of Pages : 140

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Infectious Diagnostics Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Infectious Diagnostics Market, Japan 15
3.1 Infectious Diagnostics Market, Japan, Revenue ($m), 2010-2017 15
3.2 Infectious Diagnostics Market, Japan, Revenue ($m), 2017-2024 18
3.2.1 Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), by Segment, 2010-2017 21
3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 23
3.2.3 Hepatitis Test Kits Market, Japan, Revenue ($m), by Segment, 2010-2017 25
3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 27
3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), by Segment, 2010-2017 29
3.2.6 Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2010-2017 31
3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 33
3.2.8 Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), by Segment, 2010-2017 35
3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 37
3.2.10 Retrovirus Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 39
3.2.11 Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2010-2017 41
3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), by Segment, 2017-2024 43
3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 45
3.2.14 Hepatitis Test Kits Market, Japan, Revenue ($m), by Segment, 2017-2024 47
3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 49
3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), by Segment, 2017-2024 51
3.2.17 Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2017-2024 53
3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 55
3.2.19 Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), by Segment, 2017-2024 57
3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 59
3.2.21 Retrovirus Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 61
3.2.22 Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), by Segment, 2017-2024 63
3.3 Infectious Diagnostics Market, Japan, Volume (Units), 2010-2017 65
3.4 Infectious Diagnostics Market, Japan, Volume (Units), 2017-2024 68
3.4.1 Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), by Segment, 2010-2017 71
3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), by Segment, 2010-2017 73
3.4.3 Hepatitis Test Kits Market, Japan, Volume (Units), by Segment, 2010-2017 75
3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), by Segment, 2010-2017 77
3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), by Segment, 2010-2017 79
3.4.6 Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), by Segment, 2010-2017 81
3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2010-2017 83
3.4.8 Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), by Segment, 2010-2017 85
3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2010-2017 87
3.4.10 Retrovirus Tests Market, Japan, Volume (Units), by Segment, 2010-2017 89
3.4.11 Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2010-2017 91
3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), by Segment, 2017-2024 93
3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), by Segment, 2017-2024 95
3.4.14 Hepatitis Test Kits Market, Japan, Volume (Units), by Segment, 2017-2024 97
3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), by Segment, 2017-2024 99
3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), by Segment, 2017-2024 101
3.4.17 Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), by Segment, 2017-2024 103
3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2017-2024 105
3.4.19 Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), by Segment, 2017-2024 107
3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2017-2024 109
3.4.21 Retrovirus Tests Market, Japan, Volume (Units), by Segment, 2017-2024 111
3.4.22 Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), by Segment, 2017-2024 113
3.5 Infectious Diagnostics Market, Japan, Average Price ($), 2010-2024 115
3.6 Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), 2017 121
3.7 Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), 2017 122
4 Overview of Key Companies in Japan, Infectious Diagnostics Market 124
4.1 Abbott Laboratories 124
4.1.1 Company Overview 124
4.2 F. Hoffmann-La Roche Ltd 124
4.2.1 Company Overview 124
4.3 Hologic Inc 124
4.3.1 Company Overview 124
4.4 Siemens Healthcare GmbH 125
4.4.1 Company Overview 125
4.5 Qiagen NV 125
4.5.1 Company Overview 125
4.6 Beckman Coulter Inc 125
4.6.1 Company Overview 125
4.7 Cepheid 125
4.7.1 Company Overview 125
4.8 Bio-Rad Laboratories Inc 126
4.8.1 Company Overview 126
4.9 Thermo Fisher Scientific Inc 126
4.9.1 Company Overview 126
4.10 Eiken Chemical Co Ltd 126
4.10.1 Company Overview 126
4.11 Alere Inc 126
4.11.1 Company Overview 126
5 Infectious Diagnostics Market Pipeline Products 127
6 Financial Deals Landscape 130
6.1 Partnerships 130
6.1.1 iBio Enters into Agreement with TheoremDx 130
6.1.2 Stellar Biotech Terminates Licensing Agreement with University of Guelph 131
7 Recent Developments 132
7.1 Corporate Communications 132
7.1.1 Apr 17, 2017: Toshiba Medical Names Dan Skyba Director of Ultrasound Business Unit 132
7.2 Legal And Regulatory 132
7.2.1 Oct 02, 2017: Toshiba Medical Systems: Change of company name to Canon Medical Systems 132
7.3 Other Significant Developments 132
7.3.1 Jan 26, 2017: Achievement of sales milestone for COPD products 132
8 Appendix 134
8.1 Research Methodology 135
8.1.1 Coverage 135
8.1.2 Secondary Research 135
8.1.3 Primary Research 136
8.1.4 Market Modeling and Forecasting 137
8.1.5 Company Share Analysis 138
8.1.6 Distribution Share Analysis 139
8.1.7 Benchmarking 139
8.2 GlobalData Consulting 139
8.3 Contact Us 140
8.4 Disclaimer 140

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 2: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 19
Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 5: Hepatitis Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 8: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 10: Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 12: Retrovirus Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 13: Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 16: Hepatitis Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 19: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 21: Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 23: Retrovirus Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 24: Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 25: Infectious Diagnostics Market, Japan, Volume (Units), Historic, 2010-2017 66
Table 26: Infectious Diagnostics Market, Japan, Volume (Units), Forecast, 2017-2024 69
Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 72
Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), Historic, 2010-2017 74
Table 29: Hepatitis Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 76
Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), Historic, 2010-2017 78
Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 80
Table 32: Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), Historic, 2010-2017 82
Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 84
Table 34: Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), Historic, 2010-2017 86
Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 88
Table 36: Retrovirus Tests Market, Japan, Volume (Units), Historic, 2010-2017 90
Table 37: Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 92
Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 94
Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), Forecast, 2017-2024 96
Table 40: Hepatitis Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 98
Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), Forecast, 2017-2024 100
Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 102
Table 43: Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), Forecast, 2017-2024 104
Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 106
Table 45: Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), Forecast, 2017-2024 108
Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 110
Table 47: Retrovirus Tests Market, Japan, Volume (Units), Forecast, 2017-2024 112
Table 48: Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 114
Table 49: Infectious Diagnostics Market, Japan, Average Price ($) Historic, 2010-2017 115
Table 50: Infectious Diagnostics Market, Japan, Average Price ($), Forecast, 2017-2024 118
Table 51: Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 121
Table 52: Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 123
Table 53: Infectious Diagnostics Market Pipeline Products 127
Table 54: iBio Enters into Agreement with TheoremDx 130
Table 55: Stellar Biotech Terminates Licensing Agreement with University of Guelph 131
Table 56: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 137

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 15
Figure 2: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 18
Figure 3: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 5: Hepatitis Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 7: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 8: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 9: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 33
Figure 10: Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 11: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 12: Retrovirus Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 13: Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 14: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 16: Hepatitis Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 18: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 19: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 20: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 21: Polymerase Chain Reaction (PCR) Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 22: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 23: Retrovirus Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 24: Treponema pallidum Diagnostic Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 25: Infectious Diagnostics Market, Japan, Volume (Units), Historic, 2010-2017 65
Figure 26: Infectious Diagnostics Market, Japan, Volume (Units), Forecast, 2017-2024 68
Figure 27: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 71
Figure 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), Historic, 2010-2017 73
Figure 29: Hepatitis Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 75
Figure 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), Historic, 2010-2017 77
Figure 31: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), Historic, 2010-2017 79
Figure 32: Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), Historic, 2010-2017 81
Figure 33: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 83
Figure 34: Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), Historic, 2010-2017 85
Figure 35: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 87
Figure 36: Retrovirus Tests Market, Japan, Volume (Units), Historic, 2010-2017 89
Figure 37: Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), Historic, 2010-2017 91
Figure 38: Chlamydia trichomatis Diagnostic Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 93
Figure 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Japan, Volume (Units), Forecast, 2017-2024 95
Figure 40: Hepatitis Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 97
Figure 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Japan, Volume (Units), Forecast, 2017-2024 99
Figure 42: Infectious Diagnostics Multiple Parameter Test Kits Market, Japan, Volume (Units), Forecast, 2017-2024 101
Figure 43: Infectious Diagnostics Rapid Tests & POC Market, Japan, Volume (Units), Forecast, 2017-2024 103
Figure 44: Mycobacterium tuberculosis Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 105
Figure 45: Polymerase Chain Reaction (PCR) Systems Market, Japan, Volume (Units), Forecast, 2017-2024 107
Figure 46: Post Streptococcus pyogenes Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 109
Figure 47: Retrovirus Tests Market, Japan, Volume (Units), Forecast, 2017-2024 111
Figure 48: Treponema pallidum Diagnostic Tests Market, Japan, Volume (Units), Forecast, 2017-2024 113
Figure 49: Infectious Diagnostics Market, Japan, Company Share (%) 2017 122

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

Japan Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model